OP0006 IMPROVEMENT OF ENDOTHELIAL DYSFUNCTION AND INFLAMMATION IN PSORIATIC ARTHRITIS: IMPROVE – PSA STUDY
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.5880
Abstract: Background Cardiovascular (CV) disease is leading cause of death in Psoriatic Arthritis (PsA)1. Chronic inflammation in PsA is associated with vascular endothelial dysfunction and enhanced CV risk. However, the therapeutic options to treat this enhanced… read more here.
Keywords: rosuvastatin olmesartan; psa; endothelial dysfunction; dysfunction inflammation ... See more keywords